Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6348444

Title:Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
Inventors:Chappel, Scott C.; Milton, MA, USA
Summary:Described herein are novel uses of human growth hormone for the stimulation of hematopoiesis and immune reconstitution. The invention relates to the use of human growth hormone for the manufacture of a medicament for stimulating hematopoiesis and immune reconstitution when administered to a patient approximately 30 days after transplantation of hematopoietic stem cells. Further disclosed are methods for producing a pharmaceutical composition comprised of a pharmaceutically acceptable carrier, excipient, stabilizer or auxiliary agent, and an effective amount of the human growth hormone of SEQ ID NO:1 or a fragment, analog, variant or chemical derivative thereof. Therapeutic applications include the prevention of graft rejection.
Abstract:The invention relates to the use of human growth hormone for the manufacture of a medicament for stimulating hematopoiesis and immune reconstitution to be administered to a patient in need thereof about 30 days post-transplantation of hematopoietic stem cells.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6348444
Application Number:US1999000465461
Date Filed:17/12/1999
Date Published:19/02/2002
Assignee:Applied Research Systems ARS Holding N.V., Curacao, Netherlands


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021